Related Experiment Videos
[Pleural effusion].
T Berghmans1, P Pierard, M Radermecker
1Institut Jules Bordet Service de Médecine Interne Rue Héger-Bordet 1 1000 Bruxelles.
Revue Medicale De Bruxelles
|February 15, 2003
Summary
This case study highlights a patient with non-small cell lung cancer who achieved partial remission with cisplatin and gemcitabine chemotherapy. It also discusses the differential diagnosis of a new contralateral pleural effusion.
Area of Science:
- Oncology
- Pulmonology
- Internal Medicine
Background:
- A case report detailing a patient diagnosed with non-small cell lung cancer (NSCLC) with pleural extension.
- The patient, a Spanish male, presented with advanced lung cancer requiring systemic treatment.
Observation:
- Initial treatment involved a combination chemotherapy regimen of cisplatin and gemcitabine.
- The patient experienced a significant positive response, achieving an excellent partial remission.
- Subsequently, a contralateral pleural effusion developed, accompanied by fever and weight loss.
Findings:
- The development of a contralateral pleural effusion suggests potential disease progression or a complication.
- Differential diagnosis for the new effusion is crucial for guiding further management.
- This presentation underscores the complex nature of advanced non-small cell lung cancer management.
Implications:
- Effective chemotherapy regimens can induce significant remission in advanced NSCLC.
- New effusions in cancer patients necessitate thorough investigation to rule out recurrence or complications.
- This case emphasizes the importance of vigilant monitoring and comprehensive differential diagnosis in oncology practice.